Atrial Fibrillation (Afib) Alert Wearable App Market Report 2026

The atrial fibrillation (afib) alert wearable app market size has grown rapidly in recent years. It will grow from $2.18 billion in 2025 to $2.61 billion in 2026 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular disorders, widespread adoption of wearable health devices, rising consumer awareness of heart health, growth in mobile health application usage, expansion of remote patient monitoring programs.

The atrial fibrillation (afib) alert wearable app market size is expected to see rapid growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to increasing demand for proactive cardiac care solutions, rising adoption of ai-powered wearable analytics, expansion of telecardiology services, growing integration with electronic health records, increasing focus on early afib detection. Major trends in the forecast period include increasing adoption of continuous heart rhythm monitoring, rising integration with smartwatches and fitness bands, growing use of AI-based arrhythmia detection algorithms, expansion of remote cardiac care platforms, enhanced focus on preventive heart health.

The surging demand for remote patient monitoring is expected to drive the growth of the atrial fibrillation (AFib) alert wearable app market in the coming years. Remote patient monitoring (RPM) uses digital technologies and electronic devices to collect health data outside traditional healthcare settings, enabling providers to track and manage patients’ health remotely. Demand for RPM is increasing due to the growing number of individuals living with chronic conditions such as heart disease, diabetes, and hypertension, which require continuous monitoring and timely interventions for effective management. AFib alert wearable apps support remote monitoring by continuously tracking heart rhythms, detecting irregularities in real time, and securely transmitting the data to healthcare providers. This allows timely intervention and effective management of the patient’s condition without frequent in-person visits. For example, in August 2023, a survey by Vivalink, a US-based healthcare technology company, revealed that 84% of respondents using RPM planned to increase their usage in 2024, 45% of providers utilize RPM for acute monitoring like hospital-at-home programs, and 77% anticipate that RPM-based care will surpass traditional inpatient care within the next five years. Therefore, the growing demand for remote patient monitoring is fueling the expansion of the AFib alert wearable app market.

Leading companies in the atrial fibrillation (AFib) alert wearable app market are prioritizing the development of innovative products, such as smartwatches with real-time electrocardiogram (ECG) monitoring, to detect irregular heart rhythms early and help prevent serious cardiovascular events. These smartwatches continuously track the heart’s electrical activity, enabling users to identify potential AFib or other cardiac issues promptly and take timely medical action. For example, in May 2023, Samsung Electronics Co. Ltd., a South Korea-based technology company, received U.S. Food and Drug Administration (FDA) clearance for the Irregular Heart Rhythm Notification (IHRN) feature on its Samsung Health Monitor app. Combined with the on-demand ECG function, this feature proactively monitors heart rhythms indicative of AFib, alerts users to irregularities, and prompts timely clinical intervention. Utilizing the Galaxy Watch’s BioActive Sensor, it continuously tracks heart activity in the background, providing real-time insights into cardiovascular health. Early detection of abnormal rhythms allows individuals, including those who may be asymptomatic, to take preventive measures and seek medical consultation promptly. This development reflects a broader trend in the wearable technology market, where advanced health monitoring tools are increasingly integrated into consumer devices, empowering users with actionable health data and supporting proactive management of chronic conditions like AFib.

In March 2023, HeartBeam, Inc., a US-based cardiac technology company, acquired substantially all assets of LIVMOR for an undisclosed sum. Through this acquisition, HeartBeam aims to expand its remote cardiac monitoring capabilities by integrating LIVMOR’s FDA-cleared Halo+ Atrial Fibrillation Detection System and cloud-based platform with its existing technology, enhancing patient outcomes and reducing healthcare costs. LIVMOR Inc. is a US-based digital health company specializing in AFib alert wearable technology and remote monitoring solutions.

Major companies operating in the atrial fibrillation (afib) alert wearable app market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., Koninklijke Philips N.V., Omron Healthcare Inc., Garmin Ltd., iRhythm Technologies Inc., Beurer GmbH, Bittium Corporation, Eko Devices Inc., AliveCor Inc., VitalConnect Inc., VivaLNK Inc., Biotricity Inc., Preventicus GmbH, cardiacSense Ltd., HeartBeam Inc., FibriCheck BV, CardioSignal Inc.

North America was the largest region in the atrial fibrillation (Afib) alert wearable app market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation (afib) alert wearable app market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the atrial fibrillation (afib) alert wearable app market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the afib alert wearable app market by increasing costs of imported wearable sensors, semiconductor components, connectivity modules, and mobile device hardware essential for continuous monitoring solutions. North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces cost pressure on wearable manufacturing and exports. These tariffs are increasing device prices and slowing adoption among cost-sensitive consumers. However, they are also encouraging domestic electronics manufacturing, regional supply chain diversification, and software-centric innovation that reduces hardware dependency.

The atrial fibrillation (afib) alert wearable app market research report is one of a series of new reports that provides atrial fibrillation (afib) alert wearable app market statistics, including atrial fibrillation (afib) alert wearable app industry global market size, regional shares, competitors with a atrial fibrillation (afib) alert wearable app market share, detailed atrial fibrillation (afib) alert wearable app market segments, market trends and opportunities, and any further data you may need to thrive in the atrial fibrillation (afib) alert wearable app industry. This atrial fibrillation (afib) alert wearable app market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An atrial fibrillation (AFib) alert wearable app is a mobile or wearable technology designed to monitor heart rhythms in real time and detect irregularities associated with atrial fibrillation. It provides immediate alerts when abnormal heart activity is detected, enabling timely intervention. The app works with wearable devices to continuously track cardiac patterns, support proactive heart health management, provide insights into trends over time, facilitate data sharing with healthcare providers, and guide lifestyle or treatment decisions based on real-time heart rhythm data.

The main product types of AFib alert wearable apps include standalone apps and integrated wearable devices. A standalone app operates independently on a device, performing all core functions without requiring a companion device or external software. These apps are compatible with platforms such as iOS, Android, and others, and are distributed through app stores, direct sales, and third-party vendors. Applications include remote patient monitoring, personal health tracking, clinical use, and more. End-users include hospitals and clinics, homecare providers, individual users, and others.

The atrial fibrillation (Afib) alert wearable app market consists of revenues earned by entities by providing services such as remote patient monitoring, health data analytics and reporting, medication and lifestyle management support, integration with electronic health records, insurance and clinical trial support, and user engagement and coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation (Afib) alert wearable app market also includes sales of smartwatches with electrocardiogram (ECG) sensors, portable electrocardiogram (ECG) monitors, wearable cardiac patches, hybrid smartwatches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.